SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Policy
Ex-Valeant and Philidor Execs Plead Not Guilty in Fraud Scheme
February 24, 2017
 · 
1 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Job Trends
50+ Valeant Sales Reps May Have Jumped Ship to Synergy Pharma
February 24, 2017
 · 
2 min read
Why $3.75 Billion Is The Magic Number For Valeant
February 15, 2017
 · 
1 min read
Policy
Valeant, Pershing Square to Split Legal Costs on Allergan Lawsuit
February 15, 2017
 · 
1 min read
Key Takeaways From Valeant’s Fall From Grace
February 10, 2017
 · 
1 min read
Pharm Country
Is A Valeant Turnaround Finally In The Cards?
January 31, 2017
 · 
1 min read
Business
Valeant: Is Bausch & Lomb The Next To Fall?
January 18, 2017
 · 
1 min read
Pharm Country
This Is the Smartest Move Valeant Has Made In A Really Long Time
January 12, 2017
 · 
1 min read
Anger Behind the Scenes When Valeant Jacked Up Price by 2,700% for Lead Poisoning Drug
Deals
Cosmetic Giant L’Oreal Pays $1.3 Billion for Three Skincare Brands From Valeant
January 10, 2017
 · 
3 min read
Load More
IN THE PRESS
Deals
Valeant Completes Sale Of iNova Pharma To Pacific Equity Partners And The Carlyle Group
September 29, 2017
 · 
4 min read
Policy
Valeant Provides Update On Canadian Regulatory Filing About Future Financing Plans
September 28, 2017
 · 
2 min read
Valeant Commits $200,000 To Support Hurricane Relief Efforts
September 18, 2017
 · 
1 min read
Policy
Valeant’s Tampa Facility on Track With Getting Clean Bill of Health From the FDA
August 17, 2017
 · 
3 min read
Business
Valeant Announces Second-Quarter 2017 Results
August 8, 2017
 · 
1 min read
Policy
Valeant Receives Complete Response Letter From The FDA For Latanoprostene Bunod Ophthalmic Solution, 0.024% NDA
August 8, 2017
 · 
2 min read
Valeant Announces U.S. Launch Of SILIQ (Brodalumab) Injection
July 27, 2017
 · 
6 min read
Valeant Announces Redemption Of Remaining Approximately $500 Million Aggregate Principal Amount Of Its Outstanding 6.75% Senior Notes Due 2018
July 13, 2017
 · 
3 min read
Business
Valeant Announces Q2 2017 Financial Results Date And Conference Call Details
July 11, 2017
 · 
1 min read
Valeant Pays Down $811 Million Of Senior Secured Term Loans
July 10, 2017
 · 
2 min read
Load More